Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Future Cardiology|December 21, 2020
Clinical implications and outcomes of the ORION Phase III trialsJulia Brandts, Kausik K RayCurrent Atherosclerosis Reports|July 28, 2019
PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular RiskJulia Brandts, Dirk Müller-WielandFuture Cardiology|May 8, 2020
Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetesJulia Brandts, Kausik K RayJournal of the American College of Cardiology|October 29, 2021
Familial Hypercholesterolemia: JACC Focus Seminar 4/4Julia Brandts, Kausik K RayCurrent Atherosclerosis Reports|January 8, 2025
Debate: Lipid-lowering Therapies and Diabetes DevelopmentJulia Brandts, Dirk Müller-WielandCurrent Opinion in Lipidology|June 4, 2020
Small interfering RNA to proprotein convertase subtilisin/kexin type 9: transforming LDL-cholesterol-lowering strategiesJulia Brandts, Kausik K RayExpert Opinion on Investigational Drugs|June 23, 2020
Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potentialJulia Brandts, Kausik K RayNature Reviews. Cardiology|April 13, 2023
Novel and future lipid-modulating therapies for the prevention of cardiovascular diseaseJulia Brandts, Kausik K RayHerz|August 26, 2022
[Lipid lowering: new agents and new concepts]Julia Brandts, Marlo Verket, Dirk Müller-WielandHerz|July 1, 2020
[New oral antidiabetic drugs]Dirk Müller-Wieland, Katharina Schütt, Julia Brandts, et al.Pageof 4